Biocon Ltd.

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
29-Apr-21 Motilal Oswal Approvals/faster traction to lead to better future growth Neutral 394 390 -1.02
29-Apr-21 Isec Biosimilars performance below expectations… Buy 391 400 2.3
22-Oct-18 Motilal Oswal Positive Committee opinion Neutral 658 625 -5.02
24-Sep-18 Motilal Oswal Favorable regulatory outcome enhances biosimilars prospects Buy 665 625 -6.02
11-Apr-18 SPA Securities Front runner in Biosimilars to guide revenues going ahead 612

Upcoming Events and Recent Updates

03-Dec-21
Post ITs (Interesting Article) - Biotechnology major Biocon gets USFDA approval for generic product  ( updated on Dec 03 2021)
02-Dec-21
Post ITs (Interesting Article) - Biocon enters Dow Jones Sustainability Index in Emerging Markets category  ( updated on Dec 02 2021)

Analyst Calls / Meets


Management Interviews

22-Oct-21 Kiran Mazumdar ..  
22-Oct-21 Kiran Mazumdar ..  
17-Sep-21 Kiran Mazumdar ..  
27-Jul-21 Kiran Mazumdar ..  
27-Jul-21 Kiran Mazumdar ..  

Investor Presentations


Annual Reports
Source: Reportjunction.com

2020-21  
2019-20  
2018-19  
2017-18  
2016-17  

Research Showcase

29-Apr-21
Motilal Oswal -..
Download
29-Apr-21
Isec - Quarter ..
Download
22-Oct-18
Motilal Oswal -..
Download
24-Sep-18
Motilal Oswal -..
Download
11-Apr-18
SPA Securities ..
Download

Results

29-Apr-21 Results
23-Jul-20 Results
14-May-20 Results
28-Apr-20 Results
24-Jan-20 Results

AGM/EGM/Board Meetings

24-Jul-20 - AGM
23-Jul-20 - Quarterly Results
14-May-20 - Audited Results
23-Jan-20 - Quarterly Results
26-Jul-19 - AGM

Press Release

21-Oct-21 Press Release
28-Apr-21 Press Release
01-Mar-21 Press Release
16-Feb-21 Press Release
21-Jan-21 Press Release

 

Archived Documents

No Archieved Transcript.